1. Home
  2. PNRG vs EOLS Comparison

PNRG vs EOLS Comparison

Compare PNRG & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PNRG

PrimeEnergy Resources Corporation

HOLD

Current Price

$221.30

Market Cap

307.4M

Sector

Energy

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$4.83

Market Cap

304.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PNRG
EOLS
Founded
1973
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
307.4M
304.0M
IPO Year
1995
2018

Fundamental Metrics

Financial Performance
Metric
PNRG
EOLS
Price
$221.30
$4.83
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$15.50
AVG Volume (30 Days)
30.2K
1.4M
Earning Date
04-14-2026
03-03-2026
Dividend Yield
N/A
N/A
EPS Growth
103.81
1.23
EPS
9.43
N/A
Revenue
$237,796,000.00
$297,176,000.00
Revenue This Year
N/A
$13.37
Revenue Next Year
N/A
$17.56
P/E Ratio
$23.03
N/A
Revenue Growth
79.05
11.61
52 Week Low
$126.40
$4.09
52 Week High
$238.20
$13.18

Technical Indicators

Market Signals
Indicator
PNRG
EOLS
Relative Strength Index (RSI) 65.85 48.59
Support Level $159.14 $4.74
Resistance Level N/A $4.99
Average True Range (ATR) 9.05 0.36
MACD 0.98 0.00
Stochastic Oscillator 76.58 34.88

Price Performance

Historical Comparison
PNRG
EOLS

About PNRG PrimeEnergy Resources Corporation

PrimeEnergy Resources Corp is an independent oil and natural gas company that is engaged in acquiring, developing, and producing oil and natural gas. It owns producing and non-producing properties located in Texas and Oklahoma. The company's business activities include development and exploratory drilling and providing well servicing support operations for many of the onshore oil and gas wells through its subsidiaries. It is also active in the acquisition of producing oil and gas properties through joint ventures with industry partners.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: